|
|
RENAL CLEARANCE MEASUREMENT CAN NOT BE MADE WITH ACCURACY IN PATIENTS RECEIVING THIS DRUG DUE TO INTERFERENCE WITH CHEMICAL COLOR DEVELOPMENT ESSENTIAL TO ANALYTICAL PROCEDURES
|
DRUGS CAUSING MYELOSUPPRESSION CAN EXACERBATE THE EFFECTS OF INTERFERON
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
INCREASED RISK OF BONE MARROW SUPPRESSION
|
RIFAMPICIN PLASMA LEVELS ARE INCREASED
|
CO-ADMINISTRATION HAS RESULTED IN THROMBOCYTOPENIA
|
CO-ADMINISTRATION HAS RESULTED IN THROMBOCYTOPENIA
|
CO-ADMINISTRATION HAS RESULTED IN THROMBOCYTOPENIA
|
CO-ADMINISTRATION HAS RESULTED IN THROMBOCYTOPENIA
|
CO-TRIMOXAZOLE CONCURRENT ADMINISTRATION INCREASES BIOAVAILABILITY OF THE DRUG
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|
ANTIBACTERIALS MAY INTERFERE WITH PLATELET FUNCTION OR WITH BACTERIAL SYNTHESIS OF VIT K IN THE GUT & THUS HAVE ANTICOAGULANT EFFECT OF THEIR OWN
|